English
This article is from Journal of Human Reproductive Sciences , volume 7 . Abstract BACKGROUND:: There is substantial evidence that adult stem cell populations exist in human endometrium, and hence it is suggested that either endogenous endometrial stem/progenitor cells can be activated or bone marrow derived stem cells can be transplanted in the uterine cavity for endometrial regeneration in Asherman's syndrome (AS). AIMS AND OBJECTIVES:: The objective was to evaluate the role of sub-endometrial autologous stem cell implantation in women with refractory AS in attaining menstruation and fertility. SETTING:: Tertiary care referral center. DESIGN:: Prospective case series. MATERIALS AND METHODS:: Six cases of refractory AS with failed standard treatment option of hysteroscopic adhesiolysis in the past were included. Mononuclear stem cells (MNCs) were implanted in sub-endometrial zone followed by exogenous oral estrogen therapy. Endometrial thickness (ET) was assessed at 3, 6, and 9 months. RESULTS:: Descriptive statistics and statistical analysis of study variables was carried out using STATA version 9.0. The mean MNC count was 103.3 × 106 (±20.45) with mean CD34+ count being 203,642 (
Sign in with your free account to read, download EPUBs or listen.
Ebook · Autologous stem cell transplantation in refractory Asherman's syndrome: A novel cell based therapy. · Singh, Neeta, Mohanty, Sujata, Seth, Tulika, Shankar, Meenakshi, Bhaskaran, Sruthi, Dharmendra, Sona · Internet Archive